Ruiqin Mai

Dr. Ruiqin Mai


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
GZGuohong Zhang
Guohong Zhang
SZSongxia Zhou
Songxia Zhou
WZWeixiang Zhong
Weixiang Zhong
LHLiangli Hong
Liangli Hong
YWYuanyuan Wang
Yuanyuan Wang
RMRuiqin Mai
Ruiqin Mai

30 June 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
RMRuiqin Mai
Ruiqin Mai
BHBo Huang
Bo Huang
LSLing Shen
Ling Shen
GZGuohong Zhang
Guohong Zhang
LHLiang-Li Hong
Liang-Li Hong
YCYing-Mu Cai
Ying-Mu Cai
Genotype Distribution of Human Papillomavirus in Women with Abnormal Cervical Cytology in an Esophageal Carcinoma High Incidence Area of China HPV;cervical cytological abnormalities;prevalence;Shantou, China; Infection with human papillomavirus (HPV) could affect genesis of both cervical and esophageal cancers. The type-specific distribution of HPV in cervical cytology abnormalities of women has remained unclear in Shantou, an esophageal cancer high-incidence area of China. Data from 22,617 women who were subjected to cervical HPV DNA testing with simultaneous cervical cytological examination during 2009-2013 were therefore here retrospectively evaluated in a hospital-based study. Overall, 16.2% (3,584/22,114)of women with normal cytology were HR-HPV positive, with HPV-52 (4.07%) as the most common type followed by -16 (3.63%), and -58 (2.46%). Prevalence of HR-HPV was 50.3% (253/503) in women with cervical cytological abnormalities, of which in ASC-H 71.4%, ASC-US 39.1%, HSIL 80.3% and LSIL 73.7%. HPV-58 (14.12%) was the most common type for all cervical cytological abnormalities, followed by HPV-16 (13.72%), and -52 (12.72%), while the more common HPV-16 type in ASC-H (42.9%) and HSIL (36.1%), HPV-52 and -58 were the most common types for ASC-US (10.3%) and LSIL (25%), respectively. Multiple HPV co-infections were identified in 33.2% (84/253) cytology abnormalities with positive HR-HPV, and the highest prevalence of HPV-58/16 combination in HSIL (28.6%, 6/21) was observed. Our data indicated a relative high prevalence of HPV-58 and -52 in women with cervical cytological abnormalities, which should be considered in the development of next-generation vaccines for Shantou.

15 July 2014
Verified
Journal Article
Closed access
LSLing Shen
Ling Shen
LHLiangli Hong
Liangli Hong
GZGuohong Zhang
Guohong Zhang
RMRuiqin Mai
Ruiqin Mai

1 January 2019
Verified
Journal Article
Closed access
LSLing Shen
Ling Shen
LHLiangli Hong
Liangli Hong
SZSongxia Zhou
Songxia Zhou
GZGuohong Zhang
Guohong Zhang
RMRuiqin Mai
Ruiqin Mai